Macquarie bullish on Suven Pharma, Divi's Labs, Bluejet and Syngene
Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply (...)
Site référencé: The Economic Times
The Economic Times
Shreeji Shipping sets IPO price band at Rs 240-252/ share
11/08/2025
HBL Engineering shares surge over 13% on strong Q1 earnings ; profit up 79% YoY
11/08/2025
KRBL shares surge over 18% in two days as Q1 profit surges 74% YoY
11/08/2025
Nifty could see short covering on direct rise above 24,433 : Anand James
11/08/2025
Sudip Bandyopadhyay reaffirms long-term bullish view on LIC
11/08/2025
Positive Breakout : Sanghvi Movers, Motherson Sumi among 10 stocks close cross above their 200 DMA
11/08/2025
